Vadim Baykov
- Co-authors
- Anders SundanMagne BørsetAnders WaageRandi Utne HoltTorstein B. RøCarina SeidelHenrik Hjorth‐HansenUnn‐Merete Fagerli
- Topics
- Lymphoma Diagnosis and Treatment (27 papers)Chronic Lymphocytic Leukemia Research (13 papers)Cancer Immunotherapy and Biomarkers (13 papers)
- Cited by
- HematologyHepatologyOncology
- Journals
- Journal of Biological ChemistrySHILAP Revista de lepidopterologíaBlood
- Partner nations
- RussiaNorwayUnited States
In The Last Decade
Vadim Baykov
32 papers receiving 471 citations
Peers
Comparison fields: 5 of 52
- Oncology 207
- Hematology 198
- Molecular Biology 163
- Pathology and Forensic Medicine 118
- Cell Biology 70
Countries citing papers authored by Vadim Baykov
This map shows the geographic impact of Vadim Baykov's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vadim Baykov with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vadim Baykov more than expected).
Fields of papers citing papers by Vadim Baykov
This network shows the impact of papers produced by Vadim Baykov. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vadim Baykov. The network helps show where Vadim Baykov may publish in the future.
Co-authorship network of co-authors of Vadim Baykov
This figure shows the co-authorship network connecting the top 25 collaborators of Vadim Baykov. A scholar is included among the top collaborators of Vadim Baykov based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vadim Baykov. Vadim Baykov is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 0 | |
| 4 | 0 | |
| 5 | 1 | |
| 6 | 0 | |
| 7 | 10 | |
| 8 | 12 | |
| 9 | 1 | |
| 10 | 27 | |
| 11 | 12 | |
| 12 | 1 | |
| 13 | 9 | |
| 14 | 8 | |
| 15 | Interim analysis of effectiveness and safety of Nivolumab 40 mg in relapsed/refractory Hodgkin lymphoma | 1 |
| 16 | 4 | |
| 17 | 2 | |
| 18 | 2 | |
| 19 | 35 | |
| 20 | Osteopontin is an adhesive factor for myeloma cells and is found in increased levels in plasma from patients with multiple myeloma. | 63 |
About Vadim Baykov
Vadim Baykov is a scholar working on Genetics, Pathology and Forensic Medicine and Hematology, having authored 47 papers that have together received 480 indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (27 papers), Chronic Lymphocytic Leukemia Research (13 papers) and Cancer Immunotherapy and Biomarkers (13 papers). The work is most often cited by research in Hematology (198 citations), Hepatology (62 citations) and Oncology (207 citations). Vadim Baykov has collaborated with scholars based in Russia, Norway and United States. Frequent co-authors include Anders Sundan, Magne Børset, Anders Waage, Randi Utne Holt, Torstein B. Rø, Carina Seidel, Henrik Hjorth‐Hansen, Unn‐Merete Fagerli, Ivan Moiseev and Kirill V. Lepik. Their work appears in journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.